Latest Breaking News On - United european gastroenterology - Page 23 : comparemela.com

Sexual Issues Common for GI Patients but Docs Often Avoid Topic

Lack of knowledge, too little time, and embarrassment are the main reasons gastroenterologists don t discuss the sexual dysfunction that their patients often experience, a new survey shows.

United kingdomCity ofAsma fikreeMarco romanoUniversity of campania luigi vanvitelliItalian society of gastroenterologyBarts healthUnited european gastroenterologyItalian societyRoyal london hospitalEuropean gastroenterologySexual disorderSexual dysfunctionGastrointestinal diseaseDi diseaseInflammatory bowel disease

Results of Novel Clinical Study of Guselkumab and Golimumab Combination Therapy Show Adults with Moderately to Severely Active Ulcerative Colitis Maintained Higher Rates of Clinical, Histologic, and E

Results of Novel Clinical Study of Guselkumab and Golimumab Combination Therapy Show Adults with Moderately to Severely Active Ulcerative Colitis Maintained Higher Rates of Clinical, Histologic, and E
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSpring houseBritish columbiaCraig stoltzmobileBrucee sandsJan wehkampNone of the janssen pharmaceutical companiesCrohn colitis foundationSteering committeeColitis organisation onJanssen research developmentJanssen pharmaceutical companiesJanssen pharmaceutical companies of johnsonExchange commissionIcahn school of medicine at mount sinaiCompanies of johnson

Johnson & Johnson : Results of Novel Clinical Study of Guselkumab and Golimumab Combination Therapy Show Adults with Moderately to Severely Active Ulcerative Colitis Maintained Higher Rates of Clinical, Histologic, and Endoscopic Remission at Week 38

The rate of clinical remission was 47.9 percent in patients who received combination induction therapy with guselkumab and golimumab compared with either treatment alone at 38 weeks1 . | October 10, 2022

United statesSpring houseCraig stoltzBrucee sandsNone of the janssen pharmaceutical companiesCrohn colitis foundationSteering committeeJanssen research developmentJanssen pharmaceutical companiesJanssen pharmaceutical companies of johnsonExchange commissionIcahn school of medicine at mount sinaiCompanies of johnsonColitis organisationCrohn colitis foundation of americaUnited european gastroenterology

Colonoscopy Lowers CRC Risk and Death, but Not by Much: NordICC

In an intention-to-screen analysis, 10-year results from the NordICC trial show that colonoscopy reduces the risk of colorectal cancer by only 18%.

University of washingtonUnited statesWhite river junction veterans affairs medical centerWhite river junctionDouglasj robertsonMichael bretthauerJasona dominitzMichiel maasDivision of gastroenterologyDepartment of gastroenterologyEuropean initiative on colorectal cancer nordNorwegian council of researchUs department of veterans affairsRobertson is nationalVa cooperative studies programUniversity of washington school medicine

Thousands of pancreatic cancer patients die early because their disease is MISSED on scans

University of Birmingham researchers examined 600 scans of people diagnosed with pancreatic cancer at two NHS trusts in England between 2019 and 2021.

United kingdomNosheen umarPatrick swayzeJoan crawfordLuciano pavarottiChris macdonaldUniversity of birminghamUnited european gastroenterologyPancreatic cancer united kingdom